Access cutting-edge breast cancer treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Dallas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This interventional study will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ART6043 as monotherapy or in combination with Olaparib or Niraparib.
Sponsor: Artios Pharma Ltd
Check if you qualify for this breast cancer clinical trial in Dallas, TX
If you're searching for breast cancer treatment options in Dallas, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.